Sagar Lonial

Sagar Lonial, MD, FACP

Chair and Professor
Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Chief Medical Officer
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

Explore Activities by Sagar Lonial

Title
Format
Credit Type
Credits
CCO’s Conference to Clinic Highlights From ASH 2024 Annual Meeting: Multiple Myeloma

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
CCO’s Conference to Clinic Highlights From ASH 2024 Annual Meeting: Multiple Myeloma

Content Format:

Slideset

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
An Expert’s Guide to ASH 2024: Preview of the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Conference to Clinic: Expert Analysis of the Top Multiple Myeloma Abstracts From the 2023 ASH Annual Meeting

Content Format:

Text Module

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Conference to Clinic: Expert Analysis of the 2023 ASH Top Abstracts

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

4.75
Conference to Clinic: Multiple Myeloma

Content Format:

Slideset

Credit Type:

--

Credits:

--
An Expert’s Guide to ASH 2023: Preview of the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Updates in Multiple Myeloma Care: Expert Guidance for the Multidisciplinary Teams in VHA Systems

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Multiple Myeloma: Diagnosis and Treatment for 2023

Content Format:

PDF

Credit Type:

--

Credits:

--
An Interactive Decision Support Tool: Treatment Options From 5 Experts for People With Multiple Myeloma

Content Format:

Tool

Credit Type:

--

Credits:

--
Current and Emerging Therapeutic Strategies Targeting BCMA for Relapsed/Refractory Multiple Myeloma: Guidance for the Community Multidisciplinary Team

Content Format:

Video

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Current and Emerging Therapeutic Strategies Targeting BCMA for Relapsed/Refractory Multiple Myeloma: Guidance for the Community Multidisciplinary Team

Content Format:

Slideset

Credit Type:

--

Credits:

--
BCMA-Targeting Agents in Relapsed/Refractory Multiple Myeloma: Current Approved Indications and General Management of Toxicities

Content Format:

PDF

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: Expert Recommendations on Treatment for Multiple Myeloma

Content Format:

Tool

Credit Type:

--

Credits:

--
Key Studies in Multiple Myeloma: Independent Conference Coverage of ASH 2022

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.50
An Expert’s Guide to ASH 2022: Preview of the Top Abstracts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
New Perspectives on the Treatment of Multiple Myeloma in the Relapse Setting: Case Discussion and Common Clinical Scenarios

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
Managing Multiple Myeloma in the Relapsed Setting: Expert Perspectives on Recent Advances

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
New Perspectives on the Treatment of Multiple Myeloma In The Relapse Setting: Case Discussion and Common Clinical Scenarios

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Experts Discuss the Evolution of CAR T-Cell Therapy in Multiple Myeloma

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
Investigational CAR T-Cell Therapies in Multiple Myeloma

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Key Studies in Multiple Myeloma: Independent Conference Coverage of ASH 2021

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.25
BCMA-Targeted Bispecific Antibodies: A New Approach for Relapsed/Refractory Multiple Myeloma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
An Expert’s Guide to ASH 2021: A Preview of the Top Abstracts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
FAQs on the Use of BCMA-Targeted Therapies for Relapsed or Refractory Multiple Myeloma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Next-Generation Therapeutic Strategies for Relapsed/Refractory Multiple Myeloma: Targeting BCMA

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
ExpressPointsNext-Generation Therapeutic Strategies for Relapsed/Refractory Multiple Myeloma: Targeting BCMA

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
BCMA-Targeted Antibody–Drug Conjugates in Multiple Myeloma

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Current Strategies for Targeting BCMA in R/R Myeloma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Advances in R/R Multiple Myeloma: Practical Guidance for Newly Approved and Emerging Therapies

Content Format:

Multimedia

Credit Type:

ACPE

Credits:

1.00
ExpressPoints Advances in Relapsed/Refractory Myeloma: Practical Guidance for Newly Approved and Emerging Therapies

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Advances in Relapsed/Refractory Multiple Myeloma: Practical Guidance for Newly Approved and Emerging Therapies

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Key Studies in Myeloma: CCO Independent Conference Highlights of the 2020 Virtual ASH Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.50
Expert Insights on Highlights From ASH 2020 on Multiple Myeloma

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Expert Selections From ASH 2020: Multiple Myeloma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Answering Your Questions: Ocular Toxicity With Antibody–Drug Conjugates

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Mitigation and Management of Ocular Toxicity in Patients Receiving Antibody–Drug Conjugates

Content Format:

Multimedia

Credit Type:

--

Credits:

--
An Expert’s Guide to ASH 2020: A Preview of the Top Abstracts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Treatment Options From 5 Experts for People With Multiple Myeloma: An Interactive Decision Support Tool

Content Format:

Tool

Credit Type:

--

Credits:

--
Expert Guidance on Current and Future Therapeutic Strategies for Multiple Myeloma

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Expert Guidance on Therapeutic Strategies for Multiple Myeloma

Content Format:

Text Module

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: Expert Insight on Treatment Options for Multiple Myeloma

Content Format:

Tool

Credit Type:

--

Credits:

--
New Insights in Hematologic Malignancies and Disorders: Independent Conference Coverage of the 2019 ASH Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
My Thoughts on Key Studies in Myeloma From ASH 2019

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Preview of ASH 2019: Key Expert-Selected Studies

Content Format:

Clinical Thought

Credit Type:

AMA

Credits:

1.00
Understanding the Latest Therapeutic Advances in Multiple Myeloma: Expert Guidance and Implications for Treatment Decisions

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Preview of Hot Topics at ASH 2018: Key Expert-Selected Studies

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--